IP Library Granted Patent US 8,883,123
Granted Patent B2
US 8,883,123 · App. 11/553,492 · Granted Nov 11, 2014

Use of vaccines for the treatment/prevention of the transmission of pathogens

Inventors: Juergen Daemmgen (Ochsenhausen, DE); Eric Martin Vaughn (Ames, IA)
Assignee: Boehringer Ingleheim Vetmedica, Inc.
C07K14/005A61K2039/55511C12N2760/16134A61K2039/55A61K2039/55566A61K2039/525A61K2039/552C12N2760/16122A61K39/145C12N2710/14143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,123
App. No.
11/553,492
Granted
Nov 11, 2014
Kind
B2
Abstract

The present invention relates to a method of reducing the transmission of a pathogen from an animal of a first species to an animal of a second species. Specifically, reduction of transmission is accomplished through the administration of antigen of the pathogen such that administration results in the reduction or absence of the reproduction of the pathogen in the animal to which the antigen was administered.

Claims (5)

1. A method for reducing the transmission of avian influenza virus comprising administering an antigen of avian influenza virus subtype H5 to a nonhuman mammal, wherein the administration of the antigen of avian influenza virus subtype H5 results in a reduction of the reproduction of avian influenza virus in the non-human mammal, and reduces further transmission of the avian influenza virus to a second species of mammal from the non-human mammal, wherein the antigen of avian influenza virus subtype H5 comprises a modified SEQ ID NO: 4 comprising amino acids 17-568 of SEQ ID NO: 4 lacking the amino-terminal signal peptide.

2. The method according to claim 1 , wherein modified SEQ ID NO: 4 is an adjuvanted recombinant antigen.

3. The method according to claim 2 , wherein the adjuvanted modified recombinant SEQ ID NO: 4 is produced by a recombinant baculovirus.

4. The method according to claim 1 , wherein the non-human mammal is a pig.

5. The method of claim 1 , wherein the second species of mammal is human.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jul 24, 2020
From: BOEHRINGER INGELHEIM VETMEDICA, INC.; BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
To: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Reel/Frame 053310/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2009
From: BOEHRINGER INGELHEIM VETMEDICA GMBH
To: BOEHRINGER INGELHEIM VETMEDICA, INC.
Reel/Frame 023705/0898 →
Continuity (2)
Provisional Application 60730998 · Oct 28, 2005
Related Publication 20070207168A1 · Sep 6, 2007